Latest News and Press Releases
Want to stay updated on the latest news?
-
Multiple positive data readouts during 2016 provide foundation for initiation of advanced clinical trials with three product candidates in 2017 Management to host conference call today at...
-
WALTHAM, Mass., March 06, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...